Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017
February 2017
55
About the Report
About the Report
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017
Summary
GlobalData's clinical trial report, "Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017" provides an overview of Abdominal Aortic Aneurysms clinical trials scenario. This report provides top line data relating to the clinical trials on Abdominal Aortic Aneurysms. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months
* Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to Buy
Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Products
Companies
AstraZeneca Plc, Cardoz AB, RSPR Pharma AB, Parexel International Corp, Novartis AG, Fresenius SE & Co KGaA, Fonds NutsOhra, Faron Pharmaceuticals Oy, Dr. Franz Kohler Chemie GmbH, CSL Ltd
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Clinical Trials by G7 Countries: Proportion of Abdominal Aortic Aneurysms to Cardiovascular Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20
Prominent Sponsors 21
Top Companies Participating in Abdominal Aortic Aneurysms Therapeutics Clinical Trials 22
Prominent Drugs 23
Clinical Trial Profile Snapshots 24
Appendix 52
Abbreviations 52
Definitions 52
Research Methodology 53
Secondary Research 53
About GlobalData 54
Contact Us 54
Disclaimer 54
Source 55
List of Figure
List of Figures
Abdominal Aortic Aneurysms Therapeutics, Global, Clinical Trials by Region (%), 2017* 5
Abdominal Aortic Aneurysms Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6
Abdominal Aortic Aneurysms Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 7
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 8
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 9
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 10
Proportion of Abdominal Aortic Aneurysms to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 12
Abdominal Aortic Aneurysms Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 13
Abdominal Aortic Aneurysms Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 14
Abdominal Aortic Aneurysms Therapeutics, Global, Clinical Trials by Phase (%), 2017* 15
Abdominal Aortic Aneurysms Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 16
Abdominal Aortic Aneurysms Therapeutics, Global, Clinical Trials by Trial Status, 2017* 17
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Global, by End Point Status, 2017* 18
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 19
Abdominal Aortic Aneurysms Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 20
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 21
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 22
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 23
GlobalData Methodology 53
List of Table
List of Tables
Abdominal Aortic Aneurysms Therapeutics, Global, Clinical Trials by Region, 2017* 5
Abdominal Aortic Aneurysms Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6
Abdominal Aortic Aneurysms Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 7
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 8
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 9
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, North America, Top Countries, 2017* 10
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 11
Proportion of Abdominal Aortic Aneurysms to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 12
Abdominal Aortic Aneurysms Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 13
Abdominal Aortic Aneurysms Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 14
Abdominal Aortic Aneurysms Therapeutics, Global, Clinical Trials by Phase, 2017* 15
Abdominal Aortic Aneurysms Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 16
Abdominal Aortic Aneurysms Therapeutics, Global, Clinical Trials by Trial Status, 2017* 17
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Global, by End Point Status, 2017* 18
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 19
Abdominal Aortic Aneurysms Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 20
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 21
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 22
Abdominal Aortic Aneurysms Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 23
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.